Literature DB >> 25873042

The dopamine theory of addiction: 40 years of highs and lows.

David J Nutt1, Anne Lingford-Hughes1, David Erritzoe1, Paul R A Stokes2.   

Abstract

For several decades, addiction has come to be viewed as a disorder of the dopamine neurotransmitter system; however, this view has not led to new treatments. In this Opinion article, we review the origins of the dopamine theory of addiction and discuss the ability of addictive drugs to elicit the release of dopamine in the human striatum. There is robust evidence that stimulants increase striatal dopamine levels and some evidence that alcohol may have such an effect, but little evidence, if any, that cannabis and opiates increase dopamine levels. Moreover, there is good evidence that striatal dopamine receptor availability and dopamine release are diminished in individuals with stimulant or alcohol dependence but not in individuals with opiate, nicotine or cannabis dependence. These observations have implications for understanding reward and treatment responses in various addictions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25873042     DOI: 10.1038/nrn3939

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  155 in total

Review 1.  Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?

Authors:  Nina Carlier; Victoria S Marshe; Jana Cmorejova; Caroline Davis; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 2.  Contemporary approaches to neural circuit manipulation and mapping: focus on reward and addiction.

Authors:  Benjamin T Saunders; Jocelyn M Richard; Patricia H Janak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 3.  Optogenetics enlightens neuroscience drug discovery.

Authors:  Chenchen Song; Thomas Knöpfel
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

4.  Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.

Authors:  Ana Canseco-Alba; Norman Schanz; Branden Sanabria; Juan Zhao; Zhicheng Lin; Qing-Rong Liu; Emmanuel S Onaivi
Journal:  Behav Brain Res       Date:  2018-11-30       Impact factor: 3.332

5.  Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways.

Authors:  David M Bortz; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-03-27       Impact factor: 7.853

6.  Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine.

Authors:  Ling-Yan Su; Rongcan Luo; Qianjin Liu; Jing-Ran Su; Lu-Xiu Yang; Yu-Qiang Ding; Lin Xu; Yong-Gang Yao
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

7.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

8.  Effects of reward context on feedback processing as indexed by time-frequency analysis.

Authors:  Adreanna T M Watts; Edward M Bernat
Journal:  Psychophysiology       Date:  2018-05-11       Impact factor: 4.016

9.  The habenular G-protein-coupled receptor 151 regulates synaptic plasticity and nicotine intake.

Authors:  Beatriz Antolin-Fontes; Kun Li; Jessica L Ables; Michael H Riad; Andreas Görlich; Maya Williams; Cuidong Wang; Sylvia M Lipford; Maria Dao; Jianxi Liu; Henrik Molina; Nathaniel Heintz; Paul J Kenny; Ines Ibañez-Tallon
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-25       Impact factor: 11.205

10.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.